advanced search

Welcome: Guest

log in

Arrow International, Inc. Product Pipeline Analysis

Publication Date August 2008
Publisher Global Markets Direct
Product Type Report
Pages 43
ISBN Number not applicable
Product Code GMD04813
Price

£490.00
approximately: $749 | €546

PDFBuy Now
Order above formats by FAXOrder by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Arrow International, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook Cardiovascular Devices
    • 2.5 Industry Outlook Anesthesia and Respiratory Devices
    • 2.6 Industry Outlook Diagnostic Imaging
    • 2.7 Industry Outlook Hospital Supplies
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Cardiac Care
      • 3.2.1 Overview
      • 3.2.2 Financials
      • 3.2.3 Key Strategies
    • 3.3 Critical Care
      • 3.3.1 Overview
      • 3.3.2 Financials
      • 3.3.3 Key Strategies
    • 3.4 Major Products and Services
      • 3.4.1 Overview
  • 4 History
  • 5 Business Strategy
    • 5.1 Mission Statement
    • 5.2 Strategy
    • 5.3 Corporate Social Responsibility
      • 5.3.1 Overview
  • 6 Value Chain Analysis
    • 6.1 Manufacturing
      • 6.1.1 In House Manufacturing
    • 6.2 Product Development
      • 6.2.1 Regulatory Approvals
      • 6.2.2 Clinical Trials
      • 6.2.3 Research and Development
    • 6.3 Sales and Marketing
      • 6.3.1 Partnerships and Alliances
  • 7 Competitors
  • 8 Key Employees
  • 9 Key Employee Biographies
  • 10 Company Statement
  • 11 Locations And Subsidiaries
    • 11.1 Head Office
    • 11.2 Other Locations & Subsidiaries
  • 12 Recent Developments
    • 12.1 Financial Announcements
      • 12.1.1 Aug 17, 2007: Arrow Declares Quarterly Dividend
      • 12.1.2 Jun 28, 2007: Arrow Reports Q3 Fiscal 2007 Results
      • 12.1.3 May 14, 2007: Arrow Declares Quarterly Dividend
      • 12.1.4 Mar 27, 2007: Arrow Reports Q2 Fiscal 2007 Results
      • 12.1.5 Feb 12, 2007: Arrow Declares Quarterly Dividend
      • 12.1.6 Jan 04, 2007: Arrow Reports Q1 Fiscal 2007 Results
    • 12.2 Corporate Communications
      • 12.2.1 May 31, 2007: Arrow Appoints Interim CEO
  • 13 Arrow International, Inc. Pipeline Products
    • 13.1 Arrow International, Inc. Product Pipeline Analysis
      • 13.1.1 Arrow International, Inc. Pipeline Products By Equipment Type
      • 13.1.2 Arrow International, Inc. Pipeline Products By Development Stage
      • 13.1.3 Arrow International, Inc. Pipeline Products By Therapy Area
      • 13.1.4 Arrow International, Inc. Pipeline Products By Clinical Trials
    • 13.2 CorAide Left Ventricular Assist System
      • 13.2.1 Product Description
      • 13.2.2 Product Status
      • 13.2.3 Clinical Trials
      • 13.2.4 Product Milestone
      • 13.2.5 Product Patent Details
    • 13.3 HEMOSONIC Second generation
      • 13.3.1 Product Description
      • 13.3.2 Product Status
    • 13.4 NEO PICC Catheter (Modified version)
      • 13.4.1 Product Description
      • 13.4.2 Product Status
  • 14 Appendix
    • 14.1 Methodology
      • 14.1.1 Coverage
      • 14.1.2 Secondary Research
      • 14.1.3 Primary Research
      • 14.1.4 Expert Panel Validation
    • 14.2 Contact Us
    • 14.3 About Global Markets Direct
    • 14.4 Disclaimer
  • 1 List of Tables
    • Table 1: Arrow International, Inc.,Key Facts, 2006
    • Table 2: Arrow International, Inc., Key Employees, 2006
    • Table 3: Arrow International, Inc., Subsidiaries
    • Table 4: Arrow International, Inc. Pipeline Products by Equipment Type
    • Table 5: Arrow International, Inc. Pipeline Products By Development Stage
    • Table 6: Arrow International, Inc. Pipeline Products By Therapy Area
    • Table 7: Arrow International, Inc. Pipeline Products By Clinical Trials
    • 1.2 List of Figures
    • Figure 1: Arrow International, Inc., Value Chain Analysis
    • Figure 2: Arrow International, Inc. Pipeline Products By Equipment Type
    • Figure 3: Arrow International, Inc. Pipeline Products By Equipment Type
    • Figure 4: Arrow International, Inc. Pipeline Products By Development Stage
    • Figure 5: Global Markets Direct Methodology